FDA Adverse Event Injury Summary report: N

HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE

MDR report key: 1070924 · Received July 8, 2008

Report

Report Number
2025587-2008-00052
Event Type
Injury
Date Received
July 8, 2008
Date of Event
May 13, 2008
Report Date
May 28, 2008
Manufacturer
MEDTRONIC HEART VALVES, INC.
Product Code
LWR
PMA / PMN Number
P980043
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVAL: DEVICE HISTORY REVIEWED. RESULTS: DEVICE HISTORY REVIEW FOUND THE PRODUCT MET SPECS WHEN RELEASED FOR DISTRIBUTION. ANALYSIS: RECEIVED IN VERY LITTLE CLEAR SOLUTION IN AN OPAQUE WHITE SPECIMEN CONTAINER ENCLOSED IN A SMALL PLASTIC BAG WRAPPED IN A LARGER PLASTIC BAG. ALL LEAFLETS ARE STIFF EXCEPT WHERE MINERALIZATION IS NOT PRESENT. EXTENSIVE TISSUE DETERIORATION RESULTING IN TEARS AND ABRASIONS DUE TO CONTACT WITH MINERALIZATION IS VISIBLE ON ALL CUSPS. REMNANTS OF GLISTENING OFF WHITE PANNUS REMAIN ATTACHED ADJACENT TO THE LEFT AND RIGHT CUSP MARGINS OF ATTACHMENT. RADIOGRAPHY SHOWS EXTENSIVE MINERALIZATION IN THE NON-CORONARY CUSP THAT EXTENDS ONTO THE FREE MARGIN AND BELLIES OF THE LEFT AND RIGHT CUSPS. CONCLUSION: REDUCED PERFORMANCE OF THE DEVICE DUE TO MINERALIZATION, A CONDITION ATTRIBUTED TO THE PT. DEVICE EXPLANTED AND REPLACED WITH NO REPORTED ADVERSE PT EFFECTS.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFO THAT THIS BIOPROSTHETIC AORTIC VALVE EXHIBITED HIGH GRADIENTS AND INSUFFICIENCY. THE DECISION WAS MADE TO EXPLANT THE VALVE. UPON EXPLANT, CALCIFICATION DEPOSITS WERE OBSERVED ON ALL VALVE LEAFLETS. ASSOCIATED WITH THE CALCIFICATION WERE SMALL HOLES WITH JAGGED BORDERS, INDICATIVE OF DEGRADATION DUE TO CALCIFICATION. THE OPERATIVE REPORT INDICATES THE DYSFUNCTION WAS TRIGGERED BY ENDOCARDITIS WHICH THE PT DEVELOPED IN 2007. THE VALVE WAS EXPLANTED AND REPLACED WITH NO REPORTED ADVERSE PT EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE LWR MEDTRONIC HEART VALVES, INC. T505 NA

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization| R